DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l8mhg5/epicast_report) has announced the addition of the "EpiCast Report: Acne - Epidemiology Forecast to 2022" report to their offering.
Globally, acne has a lifetime prevalence of over 90% in people of all ages, and a point-prevalence of approximately 85% in the population ages 15-24 years.
This epidemiological analysis forecasts an increase in the total prevalent cases of acne in people ages 10-44 years in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK), from 103.91 million prevalent cases in 2012 to 105.46 million prevalent cases in 2022, with a decadal growth rate of 1.5%. As GlobalData epidemiologists used steady prevalence proportions of acne over the forecast period, the growth in prevalent cases in each market can be attributed to the change in population demographics in people ages 10-44 years in the respective markets.
Although acne is not a life-endangering condition, it is associated with a huge psychosocial impact and economic burden. This report emphasizes the need for preventive measures that are directed towards high-risk groups and signifies the need for early intervention with the available effective treatments in order to tackle the increasing burden of acne.
The report provides an overview of the risk factors and global trends of acne in the 6MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast of acne prevalent cases segmented by age (in five-year increments beginning at age 0 and ending at age 44 years), sex, and stage in these six markets.
Reasons to Buy
- Develop business strategies by understanding the trends shaping and driving the global acne market.
- Quantify patient populations in the global acne market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for acne therapeutics in each of the markets covered.
- Identify the percentage of acne prevalent cases by stage.
Key Topics Covered
1 List of Tables and Figures
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.2.1 A family history of acne increases the risk of acne by four times
3.2.2 Diet is the most common aggravating factor of acne
3.2.3 The relationship between smoking and acne is unclear
3.2.4 Depression and anxiety are common comorbidities in acne patients
3.3 Global Trends
3.4 Forecast Methodology
3.5 Forecast Assumptions and Methods
3.6 Epidemiology Forecast for Acne (2012-2022)
3.7.1 Conclusions on Epidemiological Trends
3.7.2 Limitations of the Analysis
3.7.3 Strengths of the Analysis
For more information visit http://www.researchandmarkets.com/research/l8mhg5/epicast_report
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.